ZyVersa Therapeutics Total Assets Growth & History (ZVSA)
ZyVersa Therapeutics's total assets was $463,451 for fiscal 2025.
View full ZyVersa Therapeutics company overviewZyVersa Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $463,451 | −$20.1M | −97.75% |
| 2024 | 2024-12-31 | $20.6M | −$1.5M | −6.85% |
| 2023 | 2023-12-31 | $22.1M | −$96.4M | −81.34% |
| 2022 · Dec 31 | 2022-12-31 | $118.5M | $41.4M | +53.62% |
| 2021 | 2021-12-31 | $77.1M | — | — |
ZyVersa Therapeutics quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $742,223 | −$20.2M | −96.46% |
| Q4 2025 | 2025-12-31 | $463,451 | −$20.1M | −97.75% |
| Q3 2025 | 2025-09-30 | $1.0M | −$18.4M | −94.64% |
| Q2 2025 | 2025-06-30 | $19.6M | $171,607 | +0.88% |
| Q1 2025 | 2025-03-31 | $21.0M | −$665,223 | −3.07% |
| Q4 2024 | 2024-12-31 | $20.6M | −$1.5M | −6.85% |
| Q3 2024 | 2024-09-30 | $19.4M | −$13.4M | −40.87% |
| Q2 2024 | 2024-06-30 | $19.5M | −$12.5M | −39.13% |
| Q1 2024 | 2024-03-31 | $21.7M | −$93.3M | −81.17% |
| Q4 2023 | 2023-12-31 | $22.1M | −$96.4M | −81.34% |
| Q3 2023 | 2023-09-30 | $32.9M | −$46.5M | −58.62% |
| Q2 2023 | 2023-06-30 | $32.0M | −$47.2M | −59.62% |
| Q1 2023 | 2023-03-31 | $115.0M | $35.3M | +44.28% |
| Q4 2022 | 2022-12-31 | $118.5M | $41.4M | +53.62% |
| Q3 2022 | 2022-09-30 | $79.4M | — | — |
| Q2 2022 | 2022-06-30 | $79.2M | — | — |
| Q1 2022 | 2022-03-31 | $79.7M | — | — |
| Q4 2021 | 2021-12-31 | $77.1M | — | — |
ZyVersa Therapeutics total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, ZyVersa Therapeutics's total assets decreased from $77.1M to $463,451, a change of −$76.7M. The latest reported quarter, Q1 2026, shows $742,223.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ZyVersa Therapeutics source filings ↗